Literature DB >> 9420233

Characterization of replication-competent hepatitis A virus constructs containing insertions at the N terminus of the polyprotein.

Y Zhang1, G G Kaplan.   

Abstract

To determine whether hepatitis A virus (HAV) could tolerate the insertion of exogenous sequences, we constructed full-length HAV cDNAs containing in-frame insertions at the N terminus of the polyprotein and transfected the derived T7 RNA polymerase in vitro transcripts into FRhK-4 cells. Replication of HAVvec1, a construct containing an insertion of 60 nucleotides coding for a polylinker, a 2B/2C cleavage site for HAV protease 3Cpro, and two initiation codons that restored the sequence of the N terminus of the polyprotein, was detected 2 weeks after transfection by indirect immunofluorescence analysis using anti-HAV monoclonal antibodies. Western blot analysis of HAVvec1-infected cells using anti-VP2 and anti-VP4 antibodies failed to detect the expression of the inserted sequences. Insertion of a 24-mer oligonucleotide coding for a FLAG epitope into HAVvec1 resulted in its HAV-mediated expression which was retained upon deletion of a Gln residue from the inserted 2B/2C cleavage site. Western blot analysis using anti-FLAG and anti-VP2 antibodies showed that the FLAG epitope accumulated in infected cells fused to VP0. Replacement of the FLAG epitope with an epitope of the circumsporozoite protein (CSP) of Plasmodium falciparum resulted in its stable HAV-mediated expression for at least six serial passages in FRhK-4 cells. Sedimentation analysis in sucrose density gradients showed that the CSP epitope accumulated in infected cells fused to VP0, forming 80S empty capsids which also contained native VP0. Our data suggest that the HAV internal ribosome entry site can efficiently direct dual initiation of translation of the polyprotein from AUG codons separated by 66 to 78 nucleotides and show that HAV can tolerate insertions at the N terminus of the polyprotein.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9420233      PMCID: PMC109382     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Characterization of poliovirus replicons encoding carcinoembryonic antigen.

Authors:  D C Ansardi; Z Moldoveanu; D C Porter; D E Walker; R M Conry; A F LoBuglio; S McPherson; C D Morrow
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

2.  Conserved tertiary structural elements in the 5' nontranslated region of cardiovirus, aphthovirus and hepatitis A virus RNAs.

Authors:  S Y Le; J H Chen; N Sonenberg; J V Maizel
Journal:  Nucleic Acids Res       Date:  1993-05-25       Impact factor: 16.971

3.  Attenuated Mengo virus: a new vector for live recombinant vaccines.

Authors:  R Altmeyer; M Girard; S van der Werf; V Mimic; L Seigneur; M F Saron
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

4.  Engineering poliovirus as a vaccine vector for the expression of diverse antigens.

Authors:  R Andino; D Silvera; S D Suggett; P L Achacoso; C J Miller; D Baltimore; M B Feinberg
Journal:  Science       Date:  1994-09-02       Impact factor: 47.728

5.  Susceptibility of nonprimate cell lines to hepatitis A virus infection.

Authors:  A Dotzauer; S M Feinstone; G Kaplan
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

Review 6.  Internal initiation of translation of picornavirus RNAs.

Authors:  R J Jackson; S L Hunt; C L Gibbs; A Kaminski
Journal:  Mol Biol Rep       Date:  1994-05       Impact factor: 2.316

7.  Theiler's virus as a vector for foreign gene delivery.

Authors:  L Zhang; S Sato; J I Kim; R P Roos
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Attenuated Mengo virus as a vector for immunogenic human immunodeficiency virus type 1 glycoprotein 120.

Authors:  R Altmeyer; N Escriou; M Girard; A Palmenberg; S van der Werf
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

9.  Cleavage specificity of purified recombinant hepatitis A virus 3C proteinase on natural substrates.

Authors:  T Schultheiss; W Sommergruber; Y Kusov; V Gauss-Müller
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

10.  Dicistronic polioviruses as expression vectors for foreign genes.

Authors:  L Alexander; H H Lu; M Gromeier; E Wimmer
Journal:  AIDS Res Hum Retroviruses       Date:  1994       Impact factor: 2.205

View more
  9 in total

1.  Neutralization of hepatitis A virus (HAV) by an immunoadhesin containing the cysteine-rich region of HAV cellular receptor-1.

Authors:  E Silberstein; G Dveksler; G G Kaplan
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Alteration of hepatitis A virus (HAV) particles by a soluble form of HAV cellular receptor 1 containing the immunoglobin-and mucin-like regions.

Authors:  Erica Silberstein; Li Xing; Willem van de Beek; Jinhua Lu; Holland Cheng; Gerardo G Kaplan
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

3.  Determinants in 3Dpol modulate the rate of growth of hepatitis A virus.

Authors:  Krishnamurthy Konduru; Gerardo G Kaplan
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

4.  Stable growth of wild-type hepatitis A virus in cell culture.

Authors:  Krishnamurthy Konduru; Gerardo G Kaplan
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Interaction of poly(rC) binding protein 2 with the 5' noncoding region of hepatitis A virus RNA and its effects on translation.

Authors:  J Graff; J Cha; L B Blyn; E Ehrenfeld
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

6.  Characterization of recombinant hepatitis A virus genomes containing exogenous sequences at the 2A/2B junction.

Authors:  M R Beard; L Cohen; S M Lemon; A Martin
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  Growth of hepatitis A virus in a mouse liver cell line.

Authors:  Dino A Feigelstock; Peter Thompson; Gerardo G Kaplan
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 8.  Making better transgenic models: conditional, temporal, and spatial approaches.

Authors:  Sika Ristevski
Journal:  Mol Biotechnol       Date:  2005-02       Impact factor: 2.695

9.  Hepatitis A virus (HAV) packaging size limit.

Authors:  Krishnamurthy Konduru; Siham M Nakamura; Gerardo G Kaplan
Journal:  Virol J       Date:  2009-11-18       Impact factor: 4.099

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.